This week, for the first time ever, Dan is featuring two guests on the show. Regular Investor Hour listeners should instantly recognize their names... Dr. David "Doc" Eifrig and Thomas Carroll.
Doc is an MBA, former Wall Street trader, published author, and medical doctor. (Plus, he even owns a winery.) In the Stansberry Research universe, he's the editor of Retirement Millionaire, Retirement Trader, Income Intelligence, Advanced Options, and the Health & Wealth Bulletin.
Tom was once named by Fortune magazine as the No. 1 health care analyst in the U.S. His research has been referenced by health care publications and institutional investors alike, along with CNBC, Bloomberg, and Fox Business. And Stansberry readers know him for his investment expertise in the emerging legal cannabis market.
In today's interview, Tom says health care is the most promising and important economic sector of the market right now...
Some people think it's a boring sector to invest in, but I think it's paramount for every investor – for anyone who takes a self-directed or a primary interest in how they're investing their money. They have to know and have some exposure to health care. It's a $4 trillion market that's only getting bigger. It goes up each and every year.
That's why he and Doc recently joined forces with John Engel – a former biochemist and one of Stansberry's resident biotechnology experts – to launch a new research product, Prosperity Investor.
In this monthly advisory, the powerhouse team shares the best of the current industry stalwarts, next-generation medicine, emerging digital-health solutions, and much more.
On the show, Doc and Tom also share some of the biggest trends in the space. You'll hear about advancements in telemedicine, breakthrough research in immunology, and navigating the complexities in managed care.
Lastly, you won't want to miss the duo's final bit of advice for listeners... a nugget that Dan – once he removed his jaw from the floor – called "one of the best, most actionable answers ever given in the history of the show."
Dr. David Eifrig
Editor of Retirement Millionaire
Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in this industry. After earning an MBA from Northwestern University's Kellogg School of Management, he went to work as an elite derivatives trader at Goldman Sachs. He spent a decade on Wall Street with several major institutions, including Chase Manhattan and Yamaichi (then known as the "Goldman Sachs of Japan").
Editor of Cannabis Capitalist
Thomas Carroll is one of the most respected and longest-serving health care analysts on Wall Street. Prior to joining Stansberry Research, Tom worked at Legg Mason and then Stifel Financial in Baltimore for nearly two decades as managing director and senior analyst of health care.